{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:31:01Z","timestamp":1759588261267},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.toxicon.2009.02.021","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T04:30:57Z","timestamp":1236227457000},"page":"639-646","source":"Crossref","is-referenced-by-count":15,"title":["Botulinum toxin in the treatment of OAB, BPH, and IC"],"prefix":"10.1016","volume":"54","author":[{"given":"Christopher P.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3 Pt 1","key":"10.1016\/j.toxicon.2009.02.021_bib1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","article-title":"Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele","volume":"175","author":"Altaweel","year":"2006","journal-title":"J. Urol"},{"issue":"1","key":"10.1016\/j.toxicon.2009.02.021_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","article-title":"Pelvic Floor Disorders Network Refractory idiopathic urge urinary incontinence and botulinum A injection","volume":"180","author":"Brubaker","year":"2008","journal-title":"J. Urol"},{"key":"10.1016\/j.toxicon.2009.02.021_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.urology.2005.04.029","article-title":"Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates","volume":"66","author":"Chuang","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.toxicon.2009.02.021_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1464-410X.2006.06479.x","article-title":"Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia","volume":"98","author":"Chuang","year":"2006","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.toxicon.2009.02.021_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","article-title":"Histologic features in the urinary bladder wall affected from neurogenic overactivity \u2013 a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A","volume":"50","author":"Comperat","year":"2006","journal-title":"Eur. Urol"},{"issue":"5","key":"10.1016\/j.toxicon.2009.02.021_bib6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","article-title":"Neurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centre","volume":"53","author":"Del Popolo","year":"2008","journal-title":"Eur. Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.toxicon.2009.02.021_bib7","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.ju.0000143889.00681.3f","article-title":"The effect of botulinum-A toxin on patients with severe urge urinary incontinence","volume":"172","author":"Flynn","year":"2004","journal-title":"J. Urol"},{"issue":"5","key":"10.1016\/j.toxicon.2009.02.021_bib8","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/01.ju.0000177477.83991.88","article-title":"Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial","volume":"174","author":"Ghei","year":"2005","journal-title":"J. Urol"},{"issue":"1","key":"10.1016\/j.toxicon.2009.02.021_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study","volume":"172","author":"Giannantoni","year":"2004","journal-title":"J. Urol"},{"issue":"3","key":"10.1016\/j.toxicon.2009.02.021_bib10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.juro.2007.10.032","article-title":"Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year follow-up","volume":"179","author":"Giannantoni","year":"2008","journal-title":"J. Urol"},{"issue":"5","key":"10.1016\/j.toxicon.2009.02.021_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur. Urol"},{"issue":"6","key":"10.1016\/j.toxicon.2009.02.021_bib12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur. Urol"},{"issue":"5 Pt 1","key":"10.1016\/j.toxicon.2009.02.021_bib13","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(17)32480-1","article-title":"Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele","volume":"152","author":"Hernandez","year":"1994","journal-title":"J. Urol"},{"issue":"2","key":"10.1016\/j.toxicon.2009.02.021_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur. Urol"},{"issue":"3","key":"10.1016\/j.toxicon.2009.02.021_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol. Urodyn"},{"issue":"11","key":"10.1016\/j.toxicon.2009.02.021_bib16","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch. Phys. Med. Rehabil"},{"issue":"5","key":"10.1016\/j.toxicon.2009.02.021_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.toxicon.2009.02.021_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","article-title":"Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics","volume":"66","author":"Kuo","year":"2005","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.toxicon.2009.02.021_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000087173","article-title":"Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis","volume":"75","author":"Kuo","year":"2005","journal-title":"Urol. Int"},{"key":"10.1016\/j.toxicon.2009.02.021_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.urology.2004.10.077","article-title":"Prostatic botulinum A toxin injection \u2013 an alternative treatment for benign prostatic obstruction in poor surgical candidates","volume":"65","author":"Kuo","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.toxicon.2009.02.021_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.urology.2007.04.038","article-title":"Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis","volume":"70","author":"Liu","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.toxicon.2009.02.021_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief of botulinum toxin if voiding dysfunction due to benign prostatic hyperplasia: results of randomized, placebo-controlled study","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"issue":"1-2","key":"10.1016\/j.toxicon.2009.02.021_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0928-4257(01)00086-9","article-title":"Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission","volume":"96","author":"Meunier","year":"2002","journal-title":"J. Physiol. Paris"},{"issue":"5","key":"10.1016\/j.toxicon.2009.02.021_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3349\/ymj.2006.47.5.706","article-title":"Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia","volume":"47","author":"Park","year":"2006","journal-title":"Yonsei Med. J"},{"issue":"3","key":"10.1016\/j.toxicon.2009.02.021_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J. Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.toxicon.2009.02.021_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","article-title":"Botulinum toxin type A inhibits calcitonin gene-related peptide release from isolated rat bladder","volume":"175","author":"Rapp","year":"2006","journal-title":"J. Urol"},{"issue":"Suppl 4","key":"10.1016\/j.toxicon.2009.02.021_bib27","first-page":"373","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for neurogenic incontinence","volume":"169","author":"Reitz","year":"2003","journal-title":"J. Urol"},{"issue":"6","key":"10.1016\/j.toxicon.2009.02.021_bib28","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","article-title":"Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial","volume":"177","author":"Sahai","year":"2007","journal-title":"J. Urol"},{"issue":"1","key":"10.1016\/j.toxicon.2009.02.021_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid","year":"2006","journal-title":"J. Urol"},{"key":"10.1016\/j.toxicon.2009.02.021_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.toxicon.2009.02.021_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.toxicon.2009.02.021_bib32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","article-title":"Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction","volume":"48","author":"Schulte-Baukloh","year":"2005","journal-title":"Eur. Urol"},{"issue":"1","key":"10.1016\/j.toxicon.2009.02.021_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","article-title":"Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.toxicon.2009.02.021_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J. Urol"},{"issue":"1","key":"10.1016\/j.toxicon.2009.02.021_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botox Detrusor Hyperreflexia Study Team Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J. Urol"},{"issue":"1","key":"10.1016\/j.toxicon.2009.02.021_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eururo.2007.08.050","article-title":"Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption","volume":"53","author":"Silva","year":"2008","journal-title":"Eur. Urol"},{"issue":"Suppl 3","key":"10.1016\/j.toxicon.2009.02.021_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1464-410x.1998.00022.x","article-title":"Bladder autoaugmentation in myelodysplastic children","volume":"81","author":"Skobejko-Wlodarska","year":"1998","journal-title":"Br. J. Urol"},{"issue":"5","key":"10.1016\/j.toxicon.2009.02.021_bib38","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","article-title":"Botulinum toxin A has antinociceptive effects in treating interstitial cystitis","volume":"64","author":"Smith","year":"2004","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.toxicon.2009.02.021_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.toxicon.2009.02.021_bib40","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am. J. Obstet. Gynecol"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010109001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010109001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T08:31:00Z","timestamp":1558168260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010109001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0041010109001287"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2009.02.021","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}